Chronic Hepatitis C

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-07-15
EMA Authorised: Maviret (glecaprevir;pibrentasvir) — AbbVie Deutschland GmbH & Co. KG
Authorised treatment MAVIRET (glecaprevir/pibrentasvir) for chronic hepatitis C in the EU.